An Autochthonous Outbreak of the SARS-CoV-2 P.1 Variant of Concern in Southern Italy, April 2021

• Published in: Tropical medicine and infectious disease Vol. 6; no. 3; p. 151
• Main Authors: Loconsole, Daniela, Sallustio, Anna, Centrone, Francesca, Casulli, Daniele, Ferrara, Maurizio Mario, Sanguedolce, Antonio, Accogli, Marisa, Chironna, Maria
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 12.08.2021; MDPI
• Subjects: Coronaviruses; COVID-19; COVID-19 vaccines; Disease transmission; Gamma variant; Genomes; Immunization; Infections; Mutation; outbreak; P.1 variant; Patients; SARS-CoV-2 infection; Severe acute respiratory syndrome coronavirus 2; Travel; Whole genome sequencing; Brazil; Italy; COVID-19; Gamma variant; SARS-CoV-2 infection; outbreak; whole-genome sequencing; P.1 variant
• DOI: 10.3390/tropicalmed6030151
• ISSN: 2414-6366

The SARS-CoV-2 P.1 variant of concern (VOC) was first identified in Brazil and is now spreading in European countries. It is characterized by the E484K mutation in the receptor-binding domain, which could contribute to the evasion from neutralizing antibodies. In Italy, this variant was first identified in January 2021. Here, we report an autochthonous outbreak of SARS-CoV-2 P.1 variant infections in southern Italy in subjects who had not travelled to endemic areas or outside the Apulia region. The outbreak involved seven subjects, three of whom had received a COVID-19 vaccine (one had received two doses and two had received one dose). Four patients had a mild clinical presentation. Laboratory investigations of nasopharyngeal swabs revealed that all strains were S-gene target failure-negative and molecular tests revealed they were the P.1 variant. Whole-genome sequencing confirmed that five subjects were infected with closely related strains classified as the P.1 lineage. The circulation of VOCs highlights the importance of strictly monitoring the spread of SARS-CoV-2 variants through genomic surveillance and of investigating local outbreaks. Furthermore, public health measures including social distancing, screening, and quarantine for travelers are key tools to slow down the viral transmission and to contain and mitigate the impact of VOC diffusion, and rapid scaling-up of vaccination is crucial to avoid a possible new epidemic wave.